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Abstract: 
Purpose: To assess accuracy and reproducibility of MRI diagnosis of invasive placentation (IP) in high-risk 
patients and to evaluate reliability of MRI features. Secondary aim was to evaluate impact of interventional 
radiology (IR) on delivery outcomes in patients with IP at MRI. 
Methods: Twenty-six patients (mean age 36.24y/o,SD6.16) with clinical risk-factors and echographic 
suspicion of IP underwent 1.5T-MRI. Two readers reviewed images. Gold standard was histology in 
hysterectomized patients and obstetric evaluation at delivery for patients with preserved uterus. Accuracy 
and reproducibility of MRI findings were calculated. 
Results: Incidence of IP was 50% (13/26) and of PP was 11.54% (3/26). MRI showed 100% sensitivity 
(95%CI=75.3%-100%) and 92.3% specificity (95%CI=64.0%-100%) in the diagnosis of IP. Gold standard was 
histology in 10 cases and obstetric evaluation in 16. MRI findings with higher sensitivity were placental 
heterogeneity, uterine bulging and black intraplacental bands. Uterine scarring, placental heterogeneity, 
myometrial interruption and tenting of the bladder showed better specificity. MRI inter-rater agreement 
with Cohen’s K was 1. Eleven patients among 14 with MRI diagnosis of IP received IR assistance with positive 
impact on delivery outcomes in term of blood loss, red cells count, intense care unit length of stay, days of 
hospitalization and risk of being transfused. 
Conclusion: MRI is an accurate and reproducible technique in prenatal diagnosis of IP. MRI helps planning a 
safe and appropriate delivery eventually assisted by IR, which positively affects foetal and maternal 
outcomes. 
Advances in knowledge: The adoption of MRI evaluation in patients with high risk of invasive placentation 
allows a more accurate diagnosis in terms of both presence of the disease and its extension to or through 
or even beyond the myometrium. This led to a better dedicated delivery management with eventual 
adoption of interventional radiology with a global positive effect on foetal and maternal outcomes. 
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Methods: Twenty-six patients (mean age 36.24y/o,SD6.16) with clinical risk-factors and echographic 
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(95%CI=75.3%-100%) and 92.3% specificity (95%CI=64.0%-100%) in the diagnosis of IP. Gold standard was 
histology in 10 cases and obstetric evaluation in 16. MRI findings with higher sensitivity were placental 
heterogeneity, uterine bulging and black intraplacental bands. Uterine scarring, placental heterogeneity, 
myometrial interruption and tenting of the bladder showed better specificity. MRI inter-rater agreement 
with Cohen’s K was 1. Eleven patients among 14 with MRI diagnosis of IP received IR assistance with 
positive impact on delivery outcomes in term of blood loss, red cells count, intense care unit length of stay, 
days of hospitalization and risk of being transfused. 
Conclusion: MRI is an accurate and reproducible technique in prenatal diagnosis of IP. MRI helps planning a 
safe and appropriate delivery eventually assisted by IR, which positively affects foetal and maternal 
outcomes. 
Advances in knowledge: The adoption of MRI evaluation in patients with high risk of invasive placentation 
allows a more accurate diagnosis in terms of both presence of the disease and its extension to or through 
or even beyond the myometrium. This led to a better dedicated delivery management with eventual 
adoption of interventional radiology with a global positive effect on foetal and maternal outcomes. 
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Abbreviations: 
MRI: magnetic resonance imaging 
IP: invasive placentation 
IR: interventional radiology 
GS: gold standard 
CS: cesarean section(s) 
PA: placenta accreta vera 
PI: placenta increta 
PP: placenta percreta 
BMI: body mass index 
SEN: sensitivity 
SPEC: specificity  
AUROC: area under ROC curve 
PPV: positive predictive value 
NPV: negative predictive value 
IR-A: interventional radiology assisted 
IR-NA: interventional radiology non assisted 
Hb: haemoglobin 
ICU: intense care unit 
TSE: turbo spin echo 
THRIVE: T1W High Resolution Isotropic Volume Examination 
BTFE: balanced turbo field echo 
DWI: diffusion weighted images 
EPI: echo planar imaging 
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Introduction 
Placental adherence disorders are a relevant cause of maternal morbidity and mortality in peripartum 
period; among these, invasive placentation (IP) has the most severe clinical impact, which is related to 
width and depth of myometrial invasion [1, 2]. IP affects about 0.1% of all pregnancies and it comprehends 
a spectrum of conditions characterized by direct attachment of chorionic villi to the myometrium due to a 
defect of the spongiosus layer of decidua basalis, which causes increased placental-myometrial adhesion [3, 
4]. Three different entities, placenta accreta vera (PA), increta (PI) and percreta (PP)  are described figure 1. 
IP is usually silent throughout pregnancy, but causes 1% of pregnancy related haemorrhages, about 1% of 
pregnancy related death and 29% of haemorrhages requiring hysterectomy [5, 6, 7]. 
Incidence of IP is growing in last decades due to an increasing incidence of risk factors [8, 9, 10], namely 
placenta previa and surgical procedures on the myometrium such as caesarean sections (CS) or other 
uterine surgery including surgical pregnancy interruptions [11]. Prenatal diagnosis is crucial since in case of 
IP it is mandatory to plan a CS in a tertiary referral hospital for obstetric surgery with availability of blood 
products, neonatal - maternal intensive care unit and a skilled multidisciplinary team. In recent years, 
interventional radiology (IR) assistance through hypogastric or uterine artery occlusion and/or embolization 
during delivery has been introduced [12, 13, 14, 15] proving to be a safe procedure with few complications 
and a very low radiation dose administered to the foetus [16, 17]. 
The main tool for diagnosing IP is targeted ultrasonography performed between the 24th and 26th week 
[18], whose specificity and sensitivity are both reported over 90% [19]. Nevertheless, diagnostic accuracy of 
targeted ultrasonography may be affected by operator experience, availability of patient detailed clinical 
history, posterior implantation of the placenta and obesity [20]. In last two decades, Magnetic Resonance 
Imaging (MRI) emerged as a diagnostic tool to diagnose IP because, despite its overall equal or even slight 
lower accuracy [21], it allows a precise description of width and depth of placental invasion. Moreover, MRI 
does not have the same limitation, and, in case of posterior placentation, obese patients and inconclusive 
US evaluation its use is suggested by international guidelines [22]. The appropriate time point to perform 
MRI is as close as possible to the 36th week as, an earlier MRI evaluation underestimates IP [23] and 
overestimates the presence of placenta previa due to normal ascension of the placenta into the uterus 
during pregnancy. A later MRI evaluation may overestimate IP and hamper the planning of IR-assisted 
delivery in women affected by IP.  
The first aim of the present study was to assess accuracy and reproducibility of MRI diagnosis of IP in high-
risk patients and to evaluate the most accurate feature of IP. In second instance the impact of 
interventional radiology assistance on delivery outcomes in patients diagnosed with IP at MRI was 
analysed.   
Materials and Methods: 
Study design:  
A retrospective observational study was conducted on a cohort of consecutive women at intermediate or 
high risk for IP who underwent to ultrasound evaluation, performed by a dedicated Obstetric 
Gynaecologist. The study was approved by the ethics committee of the university hospital of Modena and 
Reggio Emilia. 
Patients: 
From June 2013 to November 2018, 83 women with suspicion of IP were referred to the Gynaecology 
Department. The following risk factors were considered: placenta previa, multiple previous caesarean 
sections or other surgical uterine procedures, posterior placenta, high parity defined as more than 4 
pregnancies, maternal age over 35 years and obesity defined as a BMI over 30. The patients received 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
BJ
R U
NC
OR
RE
CT
ED
 PR
OO
FS
5 
 
specific clinical examination and targeted ultrasonography evaluation performed by a dedicated Obstetric 
Gynaecologist. Twenty-six out of 83 patients were included in the study due to high risk of IP and 
underwent MRI, which was scheduled before 38th gestational week. 
MRI examinations:  
All pelvic MRI examinations for placental evaluation were performed on a 1.5T scanner (Philips Achieva, 
The Best, Netherlands) with 5-element cardiac synergy coil, after injection of an antiperistaltic drug and 
medium bladder filling. Imaging protocol included single-shot turbo spin-echo T2-weighted (TSE) and 
steady-state free precession sequences (balanced turbo field-echo BTFE) performed on utero-placental 
sagittal, axial and coronal planes, T1 weighted high resolution isotropic volume examination fat-saturated 
(THRIVE) performed on utero-placental axial and sagittal planes. Moreover, a diffusion weighted Echo 
planar imaging (EPI) was performed in axial plane. Sequences parameters are reported in table 1. In figure 2 
a normal placenta is depicted, and features of normal placentation are described. 
Images analyses: 
Two radiologists, dedicated to pelvic and gynaecological MRI, prospectively evaluated the exams. Readers 
assigned patients to three groups considering multiple radiological features of IP: non-IP, PA / PI and PP. 
Specific features of IP (figure 3) evaluated to formulate MRI diagnosis were: uterine bulging, placental 
signal heterogeneity, dark intraplacental bands, hyperintense placental lacunae, interruption of the 
myometrium and of inner myometrial layer, placental implant on previous CS uterine scar and tenting of 
the bladder [21, 24, 25, 26, 27]. Myometrium Interruption and tenting of the bladder should be considered 
a sign of extra uterine extension of placental elements typical of PP. PA and PI were considered the same 
pathology both at US and at MRI, since the difference between them is not possible at imaging. 
Interventional Radiology: 
All patients with diagnosis of IP at MRI were planned for IR-assisted delivery with the aim to reduce blood 
loss and related foetal maternal complication. In angiography room, Fogarty occlusion catheters were 
placed in both hypogastric arteries at their most proximal division with an arterial access gained with 
Seldinger technique, paying attention to foetal dose exposure. Then, patients were transferred to the 
operating room, where the CS was performed after the arterial block; in case of difficult afterbirth, 
uterotonic drugs were administrated. Fetal dose exposure was collected. Delivery-related foetal and 
maternal outcomes were registered: blood loss, hemoglobin lost in operating room, red cells transfusion, 
days spent in intense care unit, days of hospitalization, need of transfusion and hysterectomy. 
Gold Standard: 
A twofold GS [28] was adopted because a precise differentiation between PA and PI is possible only in case 
of hysterectomy and consequent histopathological evaluation of both placenta and myometrium [29]. 
Placental histological examination has low reliability for IP assessment [30] and in case of uterus 
preservation, clinical evaluation of the obstetric surgeon during CS was adopted. In case of hysterectomy, 
the pathologist was blinded to MRI findings and radiological diagnosis, while in case of surgical GS, the 
obstetric surgeon was aware of it. 
Statistical analysis: 
Descriptive statistics were performed for all demographical variables. Numerical data were expressed as 
mean and standard deviation. Diagnostic performance is evaluated on the ROC curve and the area under 
the curve (AUC), specificity (SPEC), sensitivity (SEN), PPV and NPV with respective 95% confidence intervals 
(CI0.95) were calculated for MRI diagnosis of IP, MRI diagnosis of PP and every specific feature of IP. 
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Cohen's kappa (κ) statistic was calculated in the evaluation of inter-observer agreement. According to the 
delivery management, women whit MRI diagnosis of IP were subdivided into IR-assisted (IR-A) and IR-not 
assisted (IR-NA) groups. 
Results: 
Twenty-six patients with intermediate-high risk of IP at targeted ultrasound underwent MRI: no women 
were excluded from the study. Five women required an emergency delivery before the planned CS because 
of foetal complications and three of them diagnosed with IP, could not be assisted with IR. Among 26 
patients, 11 underwent hysterectomy and histological examination was performed on removed uterus. In 
15 patients, whose uterus was preserved, surgical GS was adopted. At GS, IP was found in 13 patients with 
an incidence of 50%, and among these, 10 had PA/PI (38.46%) and 3 had PP (11.54%).  
Clinical-demographical characteristics grouped for different diagnosis are reported in table 2. 
Table 3 summarizes diagnostic accuracy and inter-rater agreement of MRI and MRI specific features 
evaluated. IP was diagnosed with MRI in 14 patients with 100% sensitivity (CI 0.95: 75.3% - 100%) and 
92,3% specificity (CI 0.95: 64.0% - 100%), with one false positive case and no missed diagnosis. The most 
accurate MRI feature of IP in our case series has been placental heterogeneity followed by uterine bulging 
and interruption of the myometrium. PP was diagnosed in 3 patients (figure 4) with 66.7% sensitivity (CI 
0.95: 9.4% - 99.2%) and 95.6% specificity (CI 0.95: 78.1% - 99.9%) with one false positive case. Moreover, 
MRI missed a PP, which was evaluated as PI but subsequently showed a focal placental percretism at GS 
(figure 5).  
MRI inter-rater agreement with Cohen’s K was 1 (CI 0.95: 1.000 - 1.000). 
Among patients with MRI diagnosis of IP, 3 were not assisted with IR and 11 patients were assisted with IR. 
In table 4 there is a summary of their outcomes. IR-NA group lost 1269.70 ml more blood in the operating 
room (CI 0.95: 225.87 ml - 2313.53 ml, P=0.0106) and required 794.55 ml red cells transfusion more (CI 
0.95: 173.89 ml - 1415.21 ml, P=0.0082). They spent 2 more days in intense care unit (CI 0.95: 0.17 - 3.89, 
P= 0.0174), stayed 29.67 more days in hospital (CI 0.95: 2.33 - 57.00) and had a relative risk of being 
transfused of 2.75 (P=0.051). Two outcomes were worse in IR-A group in comparison to IR-NA group: 
hemoglobin lost in operating room with a difference of 0.22 g (CI 0.95: -1.47 g - 1.91 g, P=0.3894) and the 
relative risk of being hysterectomized which was 0.81 because 81.18% of IR-A women needed an 
hysterectomy in comparison to only 66.67% of IR-NA women. 
In assisted patients mean time of radiation exposure was 9.84 minutes and mean administrated dose was 
121.90 mGy*cm.  
Discussion: 
MRI allows to describe the exact position of the placenta and its eventual adhesion disorders or extension 
through the myometrium with high reliability. MRI proved, also in the present study, to be a useful tool in 
the diagnosis of IP and it should be performed in presence of risk factors, doubtful placental localization 
and suspected IP as already stated in international guidelines [22]. In the reported case series, MRI was 
extremely accurate and reproducible in the diagnosis of IP with 100% sensitivity and 92.31% specificity. MRI 
had an NPV of 100% and a PPV of 92.9%. A high PPV is particularly important in order not to lose any 
eventual affected patients, while a high PPV allows to avoid over diagnosis and inappropriate IR 
procedures. Diagnostic accuracy in the recognition of PP is lower, but this result may be affected by the low 
prevalence in our series. Moreover, MRI diagnosis of IP has a very good reproducibility among dedicated 
radiologists. 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
BJ
R U
NC
OR
RE
CT
ED
 PR
OO
FS
7 
 
In the present study, the reliability of eight specific MRI features have been evaluated in the diagnosis of IP. 
The diagnostic performance described in table 3 refers to an MRI exam performed on women with high 
clinical and sonographic risk of IP. 
Two signs can be considered reliable also when present alone: placental heterogeneity and interruption of 
myometrial layer. Placental heterogeneity regards pathological development of placenta during pregnancy 
and it is typical of IP. Interruption of myometrial layer indirectly refers to the disruption of muscular fibres, 
which are substituted by placental elements (Fig. 1) and it is a precise sign of PI or PP depending to the 
extension of placenta up to or beyond the uterine serosa (Fig. 6). Another sign suggestive of PP is bladder 
tenting, although its reliability in our case series resulted to be quite low. 
The presence of other MRI features of IP should be accurately weighted because they can either represent 
a sign of IP, a variance from the normality or a sign of other placental disease. In particular uterine bulging 
and the loss of normal uterine pear shape should be differentiated by placental bulging which can be 
caused by hypertrophy of a placental lobe and it is quite common at advanced gestational age. 
Hyperintense placental lacunae in T1 weighted sequences and dark placental bands in T2 weighted images 
are an expression of the same pathological process and are a sign of placental infraction, typical of IP. They 
can be seen simultaneously or not depending on the timing of the haemorrhage. Hyperintense placental 
lacunae should be differentiated by haemorrhagic outcome of a placental abruption, because the former is 
intraplacental and the latter entities usually lies between placenta and myometrium. Dark intraplacental 
bands should be differentiated by placental septae, which are thinner and run through the placenta 
between placental lobes.  
Interruption of inner myometrial layer can be considered a reliable sign of IP and in particular of PA 
because its pathological correlation is a disruption of decidua basalis. It has a quite low specificity because 
the evaluation of this thin line at advanced gestational age is not easy. Implant on uterine scar can be 
considered as a specific manifestation of this sign because on previous scar the myometrium is mixed with 
fibrous tissue and the decidua basalis is frequently interrupted.  
The main concern performing MRI and IR on pregnant women was the safety of the mother and the child. 
Foetal SAR was kept as low as possible to obtain a diagnostic imaging and during IR only fluoroscopy was 
performed avoiding angiographic imaging. Both procedures are considered safe in the last trimester and 
are routinely performed in many centres. As regard to fetal SAR, it was not possible to find any clear 
experimental data on SAR limit or recommended values in pelvic MRI of pregnant women [31, 32]. As 
regards to IR, we obtained the mean dose administrated which was 121 mGy*cm; considering the absorbed 
foetal dose 0.15 times the entrance skin dose [33], our values can be considered safe for the mother [34] 
and the child [35] and in line with the available literature [36].  
Our results are consistent with recent studies [37] and metanalysis [38], confirming that MRI evaluation in 
case of suspected IP at sonography is highly suggested. On the other hand, some authors [39] suggested 
that US is the only diagnostic tool needed in case of suspected IP when no technical difficulties, like 
posterior placenta and obesity are present [40]. We partially agree with that but, as shown in many 
researches through the years, MRI has also a role in defining the grade of IP [41] and eventual extension to 
other pelvic organs. Moreover, the use of MRI may reduce overdiagnosis and related costs and exposure, 
for example our case series, 12/26 women with high risk at targeted sonography were then correctly 
diagnosed as non-IP at MRI examination. 
A reliable diagnosis enables to plan and perform a safe delivery in the appropriate setting, which means CS 
performed before the 40th week of gestational age in a 3rd level hospital with availability of IR assistance, a 
maternal and neonatal intense care unit and availability of blood products. In our small group of patients 
diagnosed with IP at MRI, IR assisted delivery reduced bleeding and related morbidity and length of intense 
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care unit stay and overall hospitalization and the administration of blood products. Two outcomes were 
worse in the IR-A group: haemoglobin loss in operative room and relative risk of being hysterectomized, 
although without statistical significance. The count of haemoglobin loss in operating room is probably 
biased by the fact that patients with higher blood loss, typically IR non-assisted women group, received red 
cells transfusion, which lowered the global reduction of haemoglobin count.  On the other hand, in patients 
with less blood loss, typically IR assisted women, surgeons and anaesthesiologist tried to avoid risks 
deriving from transfusion by delaying and frequently avoiding that. The higher relative risk of hysterectomy 
in the IR assisted group is related to the aim of reducing patient morbidity and not necessarily to preserve 
uterus, especially in women with high maternal age and/or with a high number of previous caesarean 
deliveries and surgical uterine procedures. 
A limitation of our study is the low number of patients included and especially the low number of women 
affected whom IR assistance was possible. Women who did not received an IR assistance due emergency 
delivery had an overall worse condition related also to the emergency delivery and that could have biased 
our results. No maternal or foetal complication were reported.  
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TABLES 
Table 1: MRI protocol. 
Exam protocol adopted for MRI evaluation of every patients. It was adapted to every woman, but in some 
cases, not every sequence could be performed. 
 
Table 2: Study population. 
Clinical characteristics of enrolled patients grouped for GS diagnosis. °Uterine surgery is the sum of every 
surgical event on the uterus including caesarean sections and surgical pregnancy interruptions; * BMI is 
referred to the beginning of the pregnancy. 
 
Table 3: Accuracy and interrater agreement of MRI. 
SEN: sensitivity, SPEC: specificity, AUROC: area under ROC curve, PPV: positive predictive value, NPV: 
negative predictive value. Cohen’s K coefficient: < 0 less than chance agreement; 0.01–0.20 slight 
agreement; 0.21– 0.40 fair agreement; 0.41–0.60 moderate agreement; 0.61–0.80 substantial agreement; 
0.81–0.99 almost perfect agreement; 1 perfect agreement. 
 
Table 4: Efficacy of interventional radiology assistance of the delivery. 
Comparison between patients assisted (IR-A) and non-assisted (IR-NA).  Hb: Haemoglobin, ICU: Intense care 
unit, rr: relative risk. 
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Figure 1: Three histological samples of human placenta. A) Haematoxylin and eosin stain of placenta 
accreta vera: chorionic villi (black square) are attached to myometrium composed of spindle cells (black 
circle), throughout decidua basalis (black arrows) which is thinned, but not interrupted. B) Desmin stain of a 
placenta increta: chorionic villi (black square) infiltrate the myometrium (black circle); decidua basalis 
cannot be identified. C) Haematoxylin and eosin stain of placenta percreta: chorionic villi (black square and 
black arrows) penetrate through the myometrium (black circle) up to the uterine serosa. 
 
Figure 2: Patient n° 7, 39 y/o at 32nd week, at 1st pregnancy. Placenta previa with no IP. A) Sagittal BTFE 
image of a previa posterior placenta. Internal cervical os (white arrow) and cervical canal (white circle). No 
uterine bulge and normal placental septae (empty arrow), which are thin hypointense lines located 
between placental lobes. B) Axial T2 wheighted TSE image. Placenta has an homogeneus intermediate T2 
signal (white arrows) and lays on the myometrium (white arrowhead), normally thinned at advamced 
maternal age.  
 
Figure 3. Patient n° 2, 40 y/o at 33rd week, at 11th pregnancy, with 1 previous CS. Placenta previa increta 
histologically confirmed. A) sagittal BTFE, B) axial T2 TSE, C) BTFE coronal images. A) uterine posterior 
bulging (white arrow) and implant of the placenta on uterine scar from previous caesarean section, where 
the myometrium is thinned (black arrowhead). No clear separation between placenta and the cervix (white 
circle). B) nodular T2 black band (black arrow) in a mild heterogeneous portion of the placenta; C) nodular 
and thick linear areas of hypointensity (blackarrow) inside a very heterogeneous portion of the placenta 
and thinning of the inner myometrial layer (black arrowhead). 
 
Figure 4: patient n° 18, 32 y/o at 35th week, at 3rd pregnancy, with 2 previous CS. Placenta previa percreta 
histologically confirmed. A) BTFE axial and B) T1 GE coronal images. A) penetration of the placental tissue 
through the myometrium which results interrupted (white arrowhead) and intraplacental nodular black 
band (white empty arrow) which correspond in B) to an hyperintense T1 spot (white arrow) representing a 
focus of haemorrhage typical of abnormal placentation. 
 
Figure 5: patient n° 5, 26 y/o at 29th week, at 1st pregnancy, with no previous CS. Placenta previa percreta 
histologically confirmed. T2 weighted coronal image. Nodular black band (arrowhead) inside a highly 
heterogeneous portion of the placenta (white dotted circle). On the left side of the uterus, the 
myometrium is interrupted (white arrows) and it is clear if compared with the opposite side where the 
myometrium is normal (empty arrow). 
 
Figure 6: patient 10, 26 y/o at 39th week, at 3rd pregnancy, with 2 previous CS. Marginal placenta previa 
percreta histologically confirmed. BTFE images A) coronal, B) sagittal. Big placental bulge (arrows), nodular 
T2 dark band (arrowheads), tenting of the bladder (empty arrows). 
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Table 1: Exam protocol 
Sequence (name) Sequence detail Acquired planes 
single-shot turbo spin-echo T2-
weighted (TSE) 
RT/ET: 3293/80 ms 
Slice thickness: 5 mm 
Acquisition matrix: 264x220 
Sagittal 
Axial 
Coronal 
three-dimensional high-resolution 
isotropic volume T1-weighted fat-
saturated (THRIVE) 
RT/ET: 3.6/1.69 ms. 
Slice thickness: 6 mm 
Acquisition matrix: 124x110 
Axial 
Sagittal 
Steady-state free precession 
sequences (balanced turbo field-echo 
BTFE) 
RT/ET: 3.5/1.77 ms  
Slice thickness: 5 mm 
Acquisition matrix: 272x212 
Sagittal 
Axial 
Coronal 
DWI; EPI imaging single shot RT/ET: 3.584/71 ms 
Slice thickness: 5 mm 
Acquisition matrix: 104x85 
B values: 0-400-800 
Axial 
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Table 2: Study population. 
 All patients (26) Non-IP (13) IP (13) PA / PI (10) PP (3) 
Age (years) 36.24 (± 6.16) 37.15 (±5.26) 35.33 (±7.05) 37.45 (± 6.47) 28.29 (±3.54) 
Gestational age (weeks) 33.81 (± 5.36) 35.00 (±2.35) 32.62 (±7.16) 32.10 (±7.84) 34.33 (±5.03) 
Previous pregnancies 3.35 (± 2.53) 2.46 (±1.20) 4.23 (±3.19) 4.80 (±3.43) 2.33 (±1.15) 
Parity 1.54 (± 1.75) 0.92 (±1.12) 2.15 (±2.08) 2.40 (±2.27) 1.33 (±1.15) 
Uterine surgery ° 1.23 (±1.11) 1.00 (±1.08) 1.46 (±1.13) 1.60 (±1.17) 1.00 (±1.00) 
BMI * 23.90 (±17.52) 23.82 (±5.94) 23.98 (±5.91) 24.22 (±6.26) 23.18 (±22.95) 
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Table 3: Accuracy and interrater agreement of MRI.   
 SEN (%) SPEC (%) AUROC PPV (%) NPV (%) Cohen’s K 
MRI 
100 
75,3 - 100 
92,31 
64,0 - 99,8 
0,962 
0,804 - 0,999 
92,9 
66,1 - 99,8 
100 
73,5 - 100 
1,000 
1,000 - 1,000 
MRI of placenta percreta 
66,7 
9,4 - 99,2 
95,7 
78,1 - 99,9 
0,812 
0,611 - 0,937 
66,7 
9,4 – 99,2 
95,7 
78,1 - 99,9 
0,708 
0,336 - 1,000 
Uterine Bulging 
92,3 
64,0 - 99,8 
84,6 
54,6 - 98,1 
0,885 
0,698 - 0,976 
85,7 
67,2 - 98,2 
91,7 
61,5 - 99,8 
0,766 
0,519 - 1,000 
Placental Heterogeneity 
100 
75,3 - 100 
100 
75,3 - 100 
1,000 
0,868 - 1,000 
100 
75,3 - 100 
100 
75,3 - 100 
0,769 
0,524 - 1,000 
Dark intraplacental bands 
84,6 
54,6 - 98,1 
76,9 
46,2 - 95,0 
0,808 
0,606 - 0,934 
78,6 
49,2 - 95,3 
83,3 
51,6 - 97,9 
1,000 
1,000 - 1,000 
Hyperintense placental lacunae 
61,5 
31,6 - 86,1 
58,3 
27,7 - 84,8 
0,599 
0,386 - 0,788 
61,5 
31,6 - 86,1 
58,3 
27,7 - 84,8 
0,516 
0,183 - 0,849 
Interruption of the myometrium 
84,6 
54,6 - 98,1 
100 
75,3 - 100 
0,923 
0,749 - 0,991 
100 
71,5 - 100 
86,7 
59,5 - 98,3 
0,846 
0,643 - 1,000 
Interruption of inner myometrial layer 
100 
75,3 - 100 
61,5 
31,6 - 86,1 
0,808 
0,606 - 0,934 
72,2 
46,5 - 90,3 
100 
63,1 - 100 
0,462 
0,100 - 0,824 
Implant on uterine scar 
53,9 
25,1 - 80,8 
100 
75,3 - 100 
0,769 
0,564 - 0,910 
100 
59,0 - 100 
68,4 
43,4 - 87,4 
0,698 
0,391 - 1,000 
Bladder tenting 
38,5 
13,9 - 68,4 
92,31 
64,0 - 99,8 
0,654 
0,443 - 0,828 
83,3 
35,9 - 99,6 
60,0 
36,1 - 80,9 
0,539 
0,195 - 0,883 
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Table 4: Efficacy of interventional radiology assistance of the delivery 
 IR-A (11) mean IR-NA (3) mean Difference 
95% C.I. of the 
difference 
P 
Blood loss (ml) 1763.64 (±805.32) 3033.33 (±57.74) 1269.70 225.87 2313.53 0.0106 
Hb lost in operating room (g) -1.59 (±0.96) -1.37 (±1.99) 0.22 -1.47 1.91 0.3894 
Red cells transfusion (ml) 305.45 (±472.79) 1100.00 (±173.20) 794.55 173.89 1415.20 0.0082 
Days in ICU (n) 1.00 (±0.77) 3.00 (±2.65) 2.00 0.17 3.83 0.0174 
Hospitalization (days) 12.00 (±9.22) 41.67 (±42.44) 29.67 2.33 57.00 0.0179 
Risk of transfusion (rr) 0.3636 1.0000 2.78   0.051 
Risk of hysterectomy (rr) 0.8182 0.6667 0.81   0.571 
 
Commented [A1]: Added RR of being hysterectomized in 
accordance to comment M of reviewer 2. 
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Table 2: Study population. 
 All patients (26) Non-IP (13) IP (13) PA / PI (10) PP (3) 
Age (years) 36.24 (± 6.16) 37.15 (±5.26) 35.33 (±7.05) 37.45 (± 6.47) 28.29 (±3.54) 
Gestational age (weeks) 33.81 (± 5.36) 35.00 (±2.35) 32.62 (±7.16) 32.10 (±7.84) 34.33 (±5.03) 
Previous pregnancies 3.35 (± 2.53) 2.46 (±1.20) 4.23 (±3.19) 4.80 (±3.43) 2.33 (±1.15) 
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Table 3: Accuracy and interrater agreement of MRI.   
 SEN (%) SPEC (%) AUROC PPV (%) NPV (%) Cohen’s K 
MRI 
100 
75,3 - 100 
92,31 
64,0 - 99,8 
0,962 
0,804 - 0,999 
92,9 
66,1 - 99,8 
100 
73,5 - 100 
1,000 
1,000 - 1,000 
MRI of placenta percreta 
66,7 
9,4 - 99,2 
95,7 
78,1 - 99,9 
0,812 
0,611 - 0,937 
66,7 
9,4 – 99,2 
95,7 
78,1 - 99,9 
0,708 
0,336 - 1,000 
Uterine Bulging 
92,3 
64,0 - 99,8 
84,6 
54,6 - 98,1 
0,885 
0,698 - 0,976 
85,7 
67,2 - 98,2 
91,7 
61,5 - 99,8 
0,766 
0,519 - 1,000 
Placental Heterogeneity 
100 
75,3 - 100 
100 
75,3 - 100 
1,000 
0,868 - 1,000 
100 
75,3 - 100 
100 
75,3 - 100 
0,769 
0,524 - 1,000 
Dark intraplacental bands 
84,6 
54,6 - 98,1 
76,9 
46,2 - 95,0 
0,808 
0,606 - 0,934 
78,6 
49,2 - 95,3 
83,3 
51,6 - 97,9 
1,000 
1,000 - 1,000 
Hyperintense placental lacunae 
61,5 
31,6 - 86,1 
58,3 
27,7 - 84,8 
0,599 
0,386 - 0,788 
61,5 
31,6 - 86,1 
58,3 
27,7 - 84,8 
0,516 
0,183 - 0,849 
Interruption of the myometrium 
84,6 
54,6 - 98,1 
100 
75,3 - 100 
0,923 
0,749 - 0,991 
100 
71,5 - 100 
86,7 
59,5 - 98,3 
0,846 
0,643 - 1,000 
Interruption of inner myometrial layer 
100 
75,3 - 100 
61,5 
31,6 - 86,1 
0,808 
0,606 - 0,934 
72,2 
46,5 - 90,3 
100 
63,1 - 100 
0,462 
0,100 - 0,824 
Implant on uterine scar 
53,9 
25,1 - 80,8 
100 
75,3 - 100 
0,769 
0,564 - 0,910 
100 
59,0 - 100 
68,4 
43,4 - 87,4 
0,698 
0,391 - 1,000 
Bladder tenting 
38,5 
13,9 - 68,4 
92,31 
64,0 - 99,8 
0,654 
0,443 - 0,828 
83,3 
35,9 - 99,6 
60,0 
36,1 - 80,9 
0,539 
0,195 - 0,883 
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Table 4: Efficacy of interventional radiology assistance of the delivery 
 IR-A (11) mean IR-NA (3) mean Difference 
95% C.I. of the 
difference 
P 
Blood loss (ml) 1763.64 (±805.32) 3033.33 (±57.74) 1269.70 225.87 2313.53 0.0106 
Hb lost in operating room (g) -1.59 (±0.96) -1.37 (±1.99) 0.22 -1.47 1.91 0.3894 
Red cells transfusion (ml) 305.45 (±472.79) 1100.00 (±173.20) 794.55 173.89 1415.20 0.0082 
Days in ICU (n) 1.00 (±0.77) 3.00 (±2.65) 2.00 0.17 3.83 0.0174 
Hospitalization (days) 12.00 (±9.22) 41.67 (±42.44) 29.67 2.33 57.00 0.0179 
Risk of transfusion (rr) 0.3636 1.0000 2.78   0.051 
Risk of hysterectomy (rr) 0.8182 0.6667 0.81   0.571 
 
